| Print
Moderna (MRNA)
Common SharesThis share can be held in a Dealing accountStocks and shares ISALifetime ISAJISASIPP
Company profile
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 35 mRNA development candidates in clinical studies as of August 2025. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
Address
200 Technology Square
Cambridge
MA
USA
02139
Telephone
+1 617 7146500
Forecast key dates
| Name | Key Date |
|---|---|
| Moderna Inc Third Quarter Earnings Conference Call for 2026 | 2026-11-06T08:00:00 |
| Moderna Inc Third Quarter Earnings Results for 2026 | 2026-11-06T00:00:00 |
| Moderna Inc Second Quarter Earnings Conference Call for 2026 | 2026-07-31T08:00:00 |
| Moderna Inc Second Quarter Earnings Results for 2026 | 2026-07-31T00:00:00 |
| Moderna Inc First Quarter Earnings Conference Call for 2026 | 2026-05-01T08:00:00 |
| Moderna Inc First Quarter Earnings Results for 2026 | 2026-05-01T00:00:00 |
| Moderna Inc Annual General Meeting for 2026 | 2026-04-30T08:00:00 |
| Moderna Inc Annual Report for 2025 | 2026-02-20T00:00:00 |
| Moderna Inc Fourth Quarter Earnings Conference Call for 2025 | 2026-02-13T08:00:00 |
| Moderna Inc Fourth Quarter Earnings Results for 2025 | 2026-02-13T00:00:00 |
| 44th annual J.P. Morgan Healthcare Conference | 2026-01-12T16:30:00 |
| Piper Sandler's 37th Annual Healthcare Conference | 2025-12-02T11:00:00 |
Previous key dates
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2025 AJ Bell. All rights reserved.